z-logo
open-access-imgOpen Access
FDA initiatives to support dose optimization in oncology drug development: the less may be the better
Author(s) -
Hanlim Moon
Publication year - 2022
Publication title -
translational and clinical pharmacology/translational and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.166
H-Index - 6
eISSN - 2383-5427
pISSN - 2289-0882
DOI - 10.12793/tcp.2022.30.e9
Subject(s) - drug development , drug , medicine , oncology , precision oncology , medical physics , pharmacology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here